As of today (2026-07-01), the Forward Annual Dividend Yield of RPG Life Sciences is 1.05%.
As of today (2026-07-01), the Trailing Annual Dividend Yield of RPG Life Sciences is 0.88%.
NSE:RPGLIFE's Forward Dividend Yield % is ranked worse than 70.5% of 505
companies
in the Drug Manufacturers industry
Industry Median: 2.12
vs NSE:RPGLIFE: 1.05
During the past 12 months, RPG Life Sciences's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 27.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of RPG Life Sciences was 44.20% per year. The lowest was -12.60% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
RPG Life Sciences (NSE:RPGLIFE) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
RPG Life Sciences Forward Dividend Yield % Related Terms
NSE:RPGLIFE vs ZTS, UTHR: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 1.05% mean?
RPG Life Sciences (NSE:RPGLIFE) has a Forward Dividend Yield % of 1.05% as of Jul. 01, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RPG Life Sciences and its competitors. According to the industry distribution chart, RPG Life Sciences ranks #356 out of 505 companies in the Drug Manufacturers industry, placing it in the top 70.5%.
Is RPG Life Sciences' Forward Dividend Yield % too high?
RPG Life Sciences' current Forward Dividend Yield % is 1.05%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.12. RPG Life Sciences' value of 1.05% is 50.5% below this industry median. Based on the distribution chart, RPG Life Sciences ranks #356 out of 505 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, RPG Life Sciences has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #356 out of 505 companies for Forward Dividend Yield %. This places RPG Life Sciences in the lower half of its industry. The industry median Forward Dividend Yield % is 2.12. RPG Life Sciences' value of 1.05% is 50.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.12, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Forward Dividend Yield % of 1.05% is 50.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Forward Dividend Yield % is 1.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,359.83, compared to a current price of ₹2,292.50 — trading 2.9% below its estimated fair value. The current Forward Dividend Yield % is 1.05% and 50.5% below the Drug Manufacturers industry median of 2.12. RPG Life Sciences' overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Forward Dividend Yield % is 1.05% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be undervalued.
The current stock price of ₹2,292.50 is trading 2.9% below its estimated GF Value™ of ₹2,359.83.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Forward Dividend Yield %: 1.05%
GF Value™: ₹2,359.83 vs. price of ₹2,292.50 (2.9% below fair value)
Industry Position: 50.5% below the Drug Manufacturers median (#356 of 505)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
93GF Score
Get the complete analysis for NSE:RPGLIFE
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 